Literature DB >> 12845741

The relationship between activated protein C-resistance and recurrent abortion.

W Dong1, W Wei, M Lin.   

Abstract

The activated protein C-resistance (APC-R) method based on APTT was used in 40 non-pregnant multiparas (control group) and 55 patients with abortion of unknown origin (experimental group) in order to explore the relationship between APC-R and recurrent abortion. A significant difference in APC-R-positive rate was found (P < 0.01) between control group and experimental group, with the rate being 5% in the controls and 25.5% in the experimental group. And the APC-R-positive rates in the patients with only twice abortions and the patients over-3-time abortions were 22.6% and 29.2%, respectively (P > 0.05). The APC-R-positive rate, which was 37.9% in the patients of late abortion, was much higher than that in the patients of early abortion. It is concluded that APC-R has something to do with recurrent abortion, and is closely related to late abortion, but bears no obvious relationship with times of abortions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 12845741     DOI: 10.1007/bf02887066

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  8 in total

1.  Activated protein C resistance can be associated with recurrent fetal loss.

Authors:  B Brenner; H Mandel; N Lanir; J Younis; H Rothbart; G Ohel; Z Blumenfeld
Journal:  Br J Haematol       Date:  1997-06       Impact factor: 6.998

2.  Development of resistance to activated protein C during pregnancy.

Authors:  A M Cumming; R C Tait; S Fildes; A Yoong; S Keeney; C R Hay
Journal:  Br J Haematol       Date:  1995-07       Impact factor: 6.998

3.  Arg506-Gln mutation in factor V and risk of thrombosis during pregnancy.

Authors:  M I Bokarewa; K Bremme; M Blombäck
Journal:  Br J Haematol       Date:  1996-02       Impact factor: 6.998

4.  Second-trimester pregnancy loss is associated with activated C resistance.

Authors:  R Rai; L Regan; E Hadley; M Dave; H Cohen
Journal:  Br J Haematol       Date:  1996-02       Impact factor: 6.998

5.  Mutation in blood coagulation factor V associated with resistance to activated protein C.

Authors:  R M Bertina; B P Koeleman; T Koster; F R Rosendaal; R J Dirven; H de Ronde; P A van der Velden; P H Reitsma
Journal:  Nature       Date:  1994-05-05       Impact factor: 49.962

6.  Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.

Authors:  B Dahlbäck; M Carlsson; P J Svensson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

7.  Studies on phospholipid antibodies, APC-resistance and associated mutation in the coagulation factor V gene.

Authors:  M I Bokarewa; K Bremme; G Falk; M Sten-Linder; N Egberg; M Blombäck
Journal:  Thromb Res       Date:  1995-05-01       Impact factor: 3.944

8.  Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives.

Authors:  M Hellgren; P J Svensson; B Dahlbäck
Journal:  Am J Obstet Gynecol       Date:  1995-07       Impact factor: 8.661

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.